Dexeus Mujer incorporates a digital system for liquid-based cytology diagnosis

Dexeus Mujer incorpora un sistema digital de diagnóstico en citología líquida

Dexeus Mujer incorporates a digital system for liquid-based cytology diagnosis

The goal is to optimise the study of cervicovaginal biological samples for cervical cancer screening

Dexeus Mujer has incorporated a new technique that will speed up and facilitate smear test analysis. It consists of a digital system that uses “liquid-based cytology” and involves introducing the samples in a liquid medium, which has an immediate preservative action, dissolves lumps, separates the cells under study from other compounds, and reduces the risk of contamination. Once the cytological preparation has been obtained, it is digitised. This technique can be applied both to the study of cervical and vaginal smear tests, which are routinely performed in gynaecological check-ups, and to the study of biopsies in order to analyse cell samples from breast tissue.

By means of artificial intelligence algorithms, the system manages to separate the images that deviate from normality, which simplifies the observation of extensions, having to interpret only the selected images, instead of the entire extension.

“Although diagnostic sensitivity is similar to the current method, it is an automated system, which reduces observation time and provides a faster diagnosis. In addition, liquid-based cytology allows for better preservation and facilitates sample analysis”, explains Dr Francesc Tresserra, Director of R&D&I in Gynaecology and head of the Cytology Laboratory at Dexeus Mujer.

“Another positive aspect is that it provides a temporary reservoir of the patient’s cells in case additional analyses are needed, such as the determination of the human papillomavirus (HPV), and therefore avoids having to resort to a new sample collection”. The Cytology Laboratory at Dexeus Mujer currently analyses around 80,000 cytologies per year. This new system will increase the speed of analysis and bring this figure up to more than 100,000 from January 2023.

Aspecto citológico células (Papanicolaou)

¿Cómo podemos ayudarte?

Te informamos que los datos de carácter personal que proporciones rellenando el presente formulario serán tratados por Fundación Dexeus Mujer como responsable de esta web. La finalidad de la recogida y tratamiento de estos datos es contactar contigo en referencia a tu solicitud y en caso de que expresamente nos autorices enviarte información sobre actividades, promociones y/o servicios y nuestro boletín informativo periódico. La legitimación se realiza a través del consentimiento del interesado. Podrás ejercer tus derechos de acceso, rectificación, limitación y suprimir los datos ante el delegado de protección de datos en así como el derecho a presentar una reclamación ante una autoridad de control. Puedes consultar la información adicional y detallada sobre Protección de Datos en nuestra política de privacidad.

How can we help you?

We inform you that the personal data that you provide by filling in this form will be treated by Dexeus Mujer Foundation as responsible for this website. The purpose of collecting and processing this data is to contact you regarding your request and in the event that you expressly authorize us to send you information on activities, promotions and / or services and our periodic newsletter. The legitimation is carried out through the consent of the interested party. You can exercise your rights of access, rectification, limitation and delete the data before the data protection officer at as well as the right to file a claim with a control authority. You can consult the additional and detailed information on Data Protection in our privacy policy.